Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.   

RSS icon
Gene editing software image from Scribe Therapeutics for its STX-1150 drug to treat LDL-C.

Coming soon: First-in-human study of gene-modifying drug for hypercholesterolemia

Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.

Anthony Fletcher, MD, FACC FAHA, FSCAI, president of the Association of Black Cardiologists (ABC), and an interventional cardiologist at CHI St. Vincent Heart Clinic Arkansas, Little Rock, explains the results of a recent ABC survey looking at the level of awareness among providers and communities in cardiology care deserts in the South. He said there was a poor level of understanding about LDL-C management and Lp(a) awareness among both primary care providers and patients in these underserved areas.

New ABC campaign works to improve care in cardiology deserts

Association of Black Cardiologists President Anthony Fletcher, MD, discusses the group's efforts to educate patients in Louisiana, Arkansas, Georgia and Mississippi.

heart doctor cardiologist

New-look heart failure treatment shows early promise

Reducing the activity of a specific protein could provide significant relief for many heart failure patients.

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system

FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information

The FDA finalized four Class I recalls related to safety concerns first reported by Abbott in November. Meanwhile, a Florida man who uses these sensors to manage his diabetes has already filed a lawsuit over the issue.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

Cardiovascular health in the United States: Exploring the good, the bad and the ugly

A new comprehensive report detailed the latest stats and trends in hypertension, coronary heart disease, stroke and many other areas of interest. “Progress in cardiovascular health depends on knowing where we stand,” the authors wrote. “To improve, we must measure—not occasionally, but consistently, transparently and with purpose.”

Medtronic has received U.S. Food and Drug Administration (FDA) clearance for the MiniMed Go Smart Multiple Daily Injection system.

FDA clears Medtronic’s new smart diabetes management app

Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.

The U.S. Food and Drug Administration (FDA) has announced that Modern Warrior is recalling all lots of its Modern Warrior Ready capsules, a dietary supplement marketed as a way to boost metabolism, improve brain function and reduce cravings.

‘Mental clarity’ supplement recalled due to risk of cardiovascular events, suicidal thoughts

This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately. 

Thumbnail

FDA announces supplement recall over risk of heart attack or stroke

Silintan is a dietary supplement marketed as a treatment for joint and body aches. According to a recent analysis by the FDA, however, all lots contained undeclared meloxicam, creating an increased risk of adverse events.

Displaying 25 - 32 of 441
Design by Adaptive Theme